Total Payments
$4,891
2024 Payments
$560.17
Companies
29
Transactions
246
Medicare Patients
5,847
Medicare Billing
$602,287
Payment Breakdown by Category
Food & Beverage$4,750 (97.1%)
Education$141.23 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,750 | 243 | 97.1% |
| Education | $141.23 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $683.12 | 20 | $0 (2024) |
| Allergan, Inc. | $601.58 | 19 | $0 (2020) |
| ViiV Healthcare Company | $539.15 | 44 | $0 (2024) |
| Gilead Sciences, Inc. | $532.70 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $495.10 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $335.62 | 14 | $0 (2022) |
| Melinta Therapeutics, LLC | $314.85 | 20 | $0 (2024) |
| ABBVIE INC. | $257.92 | 9 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $165.08 | 6 | $0 (2022) |
| Theravance Biopharma, Inc. | $124.60 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.17 | 23 | ABBVIE INC. ($138.12) |
| 2023 | $636.67 | 35 | ViiV Healthcare Company ($130.01) |
| 2022 | $510.73 | 15 | Insmed, Inc. ($198.98) |
| 2021 | $282.74 | 14 | Insmed, Inc. ($63.47) |
| 2020 | $634.28 | 26 | Insmed, Inc. ($146.02) |
| 2019 | $883.41 | 48 | Allergan Inc. ($273.67) |
| 2018 | $665.51 | 45 | Melinta Therapeutics, Inc. ($141.34) |
| 2017 | $717.36 | 40 | Allergan Inc. ($115.56) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.14 | General |
| 09/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ANTIBIOTIC | ||||||
| 09/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.57 | General |
| 08/28/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTIFUNGALS | ||||||
| 07/31/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: ANTIFUNGALS | ||||||
| 07/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 06/19/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Vabomere, Kimyrsa | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ANTIFUNGALS | ||||||
| 06/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: HIV | ||||||
| 05/27/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: HIV | ||||||
| 05/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/14/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/01/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: HIV | ||||||
| 02/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Respiratory | ||||||
| 02/21/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Vabomere, Kimyrsa | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: ANTIFUNGALS | ||||||
| 02/14/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: HIV | ||||||
| 02/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: VIROLOGY | ||||||
| 02/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/20/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: HIV | ||||||
| 12/20/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,453 | 1,799 | $307,840 | $157,136 |
| 2022 | 13 | 1,439 | 1,783 | $294,585 | $147,395 |
| 2021 | 15 | 1,520 | 1,793 | $288,805 | $149,112 |
| 2020 | 11 | 1,435 | 1,750 | $288,715 | $148,644 |
Total Patients
5,847
Total Services
7,125
Medicare Billing
$602,287
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 538 | 760 | $95,000 | $50,456 | 53.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 292 | 304 | $76,000 | $33,043 | 43.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 236 | 308 | $61,600 | $30,486 | 49.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 164 | 164 | $41,820 | $23,721 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 114 | $19,950 | $11,502 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $4,000 | $2,955 | 73.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 65 | 70 | $6,300 | $2,886 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,700 | $1,692 | 62.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 47 | $470.00 | $394.80 | 84.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 499 | 699 | $87,375 | $41,965 | 48.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 281 | 288 | $72,000 | $32,771 | 45.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 136 | 138 | $35,190 | $23,082 | 65.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 206 | 266 | $53,200 | $22,827 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 137 | $23,975 | $14,242 | 59.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 20 | $4,000 | $2,955 | 73.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 84 | 85 | $7,650 | $2,756 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,375 | $2,161 | 64.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,300 | $2,094 | 63.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $1,980 | $936.76 | 47.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $1,020 | $822.48 | 80.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 17 | $680.00 | $534.61 | 78.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 49 | 84 | $840.00 | $249.03 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 482 | 653 | $81,625 | $39,918 | 48.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 279 | 284 | $71,000 | $32,754 | 46.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 150 | 151 | $38,505 | $25,772 | 66.9% |
About Dr. Donald Marcus, M.D
Dr. Donald Marcus, M.D is a Infectious Disease healthcare provider based in Southampton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003880071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Marcus, M.D has received a total of $4,891 in payments from pharmaceutical and medical device companies, with $560.17 received in 2024. These payments were reported across 246 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,750).
As a Medicare-enrolled provider, Marcus has provided services to 5,847 Medicare beneficiaries, totaling 7,125 services with total Medicare billing of $602,287. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Southampton, PA
- Active Since 02/15/2006
- Last Updated 05/18/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1003880071
Products in Payments
- Arikayce (Drug) $683.12
- DALVANCE (Drug) $488.68
- PREZCOBIX (Drug) $279.04
- DOVATO (Drug) $231.11
- AVYCAZ (Drug) $226.38
- VIBATIV (Drug) $220.73
- ISENTRESS (Drug) $167.20
- Baxdela (Drug) $137.10
- TRIUMEQ (Drug) $129.61
- TEFLARO (Drug) $126.98
- MINOCIN IV (Drug) $106.47
- Rezzayo (Drug) $106.06
- XARELTO (Drug) $103.43
- DIFICID (Drug) $98.14
- ZERBAXA (Drug) $83.08
- Xerava (Drug) $82.41
- CABENUVA (Biological) $82.09
- PIFELTRO (Drug) $78.49
- Hizentra (Biological) $75.67
- Vibativ (Drug) $68.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Southampton
Dr. William Pace, Md, MD
Infectious Disease — Payments: $439,798
Infectious Disease $439,798
George Poporad, M.d, M.D
Infectious Disease — Payments: $4,096
Infectious Disease $4,096
Dr. Divya Sareen, M.d, M.D
Infectious Disease — Payments: $3,467
Infectious Disease $3,467
Dr. Richard Tepper, M.d, M.D
Infectious Disease — Payments: $2,043
Infectious Disease $2,043
Dr. Rajeev Fernando, M.d, M.D
Infectious Disease — Payments: $1,221
Infectious Disease $1,221
Dr. Angela Lawton, M.d, M.D
Infectious Disease — Payments: $719.06
Infectious Disease $719.06